Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 9 registrations
- Sodium Phosphates1.34GM/5ML; 1.38GM/5ML (268MG/ML, 13.4GM/50ML; 13.8GM/50ML (268MG/ML, 4.02GM/15ML; 4.14GM/15ML (268MG/ML · solution · Fresenius Kabi USA
- Sodium Phosphates in Plastic Container4.02GM/15ML; 4.14GM/15ML (268MG/ML · solution · Hospira
- Monobasic Sodium Phosphate and Dibasic Sodium Phosphate0.398GM; 1.102GM · tablet · Novel Labs INC
- Osmoprep0.398GM; 1.102GM · tablet · Salix Pharms
At a glance
- Registers
- 1
- Registrations
- 9
- With their own page
- 9
- Companies
- 4
All medicines with Monohydrate
Human medicines from every register that match Monohydrate by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
907 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Bosutinib Monohydrate | United States | 100MG BASE, 500MG BASE | tablet | Marketed | Alembic |
| Nitrofurantoin (Monohydrate/Macrocrystals)Combination | United States | 75MG; 25MG | capsule | Marketed | Alvogen |
| Monobasic Sodium Phosphate and Dibasic Sodium PhosphateCombination | United States | 0.398GM; 1.102GM | tablet | Marketed | Novel Labs INC |
| Sodium PhosphatesCombination | United States | 1.34GM/5ML; 1.38GM/5ML (268MG/ML, 13.4GM/50ML; 13.8GM/50ML (268MG/ML, 4.02GM/15ML; 4.14GM/15ML (268MG/ML | solution | Marketed | Fresenius Kabi USA |
| Sodium Phosphates in Plastic ContainerCombination | United States | 4.02GM/15ML; 4.14GM/15ML (268MG/ML | solution | Marketed | Hospira |
| Bosulif | United States | 100MG BASE, 50MG BASE | capsule | Marketed | PF Prism CV |
| Bosulif | United States | 100MG BASE, 400MG BASE, 500MG BASE | tablet | Marketed | PF Prism CV |
| OsmoprepCombination | United States | 0.398GM; 1.102GM | tablet | Not marketed | Salix Pharms |
| VisicolCombination | United States | 0.398GM; 1.102GM | tablet | Not marketed | Salix Pharms |
| Jampzinc-HCCombination | Canada | 0.5 % / W/W + 0.5 % / W/W | Ointment | Marketed | Jamp Pharma Corporation |
| Mezlin | United States | 1GM BASE/VIAL, 20GM BASE/VIAL, 2GM BASE/VIAL … | injectable | Not marketed | Bayer Pharms |
| Beconase Aq | United States | 0.042MG DIPROP/SPRAY | spray, metered | Not marketed | Glaxosmithkline |
| Propulsid | United States | 1MG BASE/ML | suspension | Not marketed | Janssen Pharms |
| Propulsid | United States | 10MG BASE, 20MG BASE | tablet | Not marketed | Janssen Pharms |
| Propulsid Quicksolv | United States | 20MG BASE | tablet, orally disintegrating | Not marketed | Janssen Pharma |
| Vancenase Aq | United States | 0.042MG DIPROP/SPRAY, 0.084MG DIPROP/SPRAY | spray, metered | Not marketed | Schering |
| Sitagliptin / Metformin hydrochloride MylanCombination | European Union | Authorised | Mylan Pharmaceuticals Limited | ||
| Zometa Concentrate | Canada | 4 MG / 5 ML | Solution | Marketed | Novartis Pharmaceuticals Canada INC |
| Fotivda | European Union | Authorised | Recordati Netherlands B.V. | ||
| Stayveer | European Union | Authorised | Janssen-Cilag International NV | ||
| Tecovirimat SIGA | European Union | Authorised | SIGA Technologies Netherlands B.V. | ||
| Mometasone | Canada | 50 MCG / ACT | Spray (Metered-Dose) | Marketed | Sanis Health INC |
| Mometasone | Canada | 50 MCG / ACT | Spray (Metered-Dose) | Marketed | Sivem Pharmaceuticals Ulc |
| Risedronate | Canada | 35 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Teva-Risedronate | Canada | 5 MG | Tablet | Marketed | Teva Canada Limited |